Elawyers Elawyers
Washington| Change

In re Lupron Marketing and Sales Practices Litigation, 01-CV-10861-RGS. (2018)

Court: District Court, D. Massachusetts Number: infdco20180504g07 Visitors: 5
Filed: May 03, 2018
Latest Update: May 03, 2018
Summary: ORDER FOR ISSUANCE OF CY PRES PAYMENT TO DANA FARBER CANCER INSTITUTE IN SUPPORT OF THE MAZZONE AWARDS PROGRAM RICHARD G. STEARNS , District Judge . On May 1, 2018, the court granted Dana-Farber/Harvard Cancer Center (DF/HCC) and the Prostate Cancer Foundation's (PCF) request to extend the end date of the Mazzone Program to September 30, 2018, and to use unspent funding to support further research. The unspent funds held by the court from the Lupron Class Settlement Pool surplus is current
More

ORDER FOR ISSUANCE OF CY PRES PAYMENT TO DANA FARBER CANCER INSTITUTE IN SUPPORT OF THE MAZZONE AWARDS PROGRAM

On May 1, 2018, the court granted Dana-Farber/Harvard Cancer Center (DF/HCC) and the Prostate Cancer Foundation's (PCF) request to extend the end date of the Mazzone Program to September 30, 2018, and to use unspent funding to support further research. The unspent funds held by the court from the Lupron® Class Settlement Pool surplus is currently $101,456.57. The court ORDERS the Court Registry Investment System to issue a check in the amount of $50,728.29 to Dana Farber Cancer Institute d/b/a Dana-Farber/Harvard Cancer Center to be deposited into a dedicated account and used for the purposes set out in DF/HCC and PCF's April 30, 2018 proposal. See Dkt #592 at 3-4. The court will disperse the balance of the funds upon its approval of the final research progress and accounting report (due September 30, 2018).

SO ORDERED.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer